Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease

  • Wiggins B
  • Knight K
  • Banno F
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Celiac disease (CD) is an autoimmune disorder that predominantly affects the small intestine and is related to antibodies created against gluten when the substance is ingested. It is uncommon comorbidity in patients with Hashimoto's thyroiditis (HT). Myxedema is a severe form of hypothyroidism that is commonly related to new diagnoses, medication non-compliance, or malabsorption of thyroid supplementation that can have life-threatening associated conditions like heart failure and coma. In this article, we will describe a case of myxedema secondary to levothyroxine malabsorption in the setting of a newly diagnosed CD.

Cite

CITATION STYLE

APA

Wiggins, B., Knight, K. T., Banno, F., & Minaudo, M. (2022). Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease. Cureus. https://doi.org/10.7759/cureus.25491

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free